Biora Therapeutics, Inc.

The momentum for this stock is not very good. Biora Therapeutics, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Biora Therapeutics, Inc. .
Log in to see more information.

News

Biora Therapeutics achieves ISO 13485 certification
Biora Therapeutics achieves ISO 13485 certification

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Biora Therapeutics Achieves ISO 13485 Certification
Biora Therapeutics Achieves ISO 13485 Certification

Globe Newswire Underscoring the company's commitment to quality and excellenceSAN DIEGO, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic...\n more…

Biora Therapeutics granted extension to regain compliance with Nasdaq
Biora Therapeutics granted extension to regain compliance with Nasdaq

Seeking Alpha - Healthcare Biora Therapeutics granted extension to regain compliance with Nasdaq...\n more…

Biora Therapeutics granted extension to regain compliance with Nasdaq
Biora Therapeutics granted extension to regain compliance with Nasdaq

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Biora Therapeutics Announces Positive Nasdaq Listing Decision
Biora Therapeutics Announces Positive Nasdaq Listing Decision

Globe Newswire Company granted extension to regain compliance with Nasdaq listing requirementsSAN DIEGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining...\n more…

Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference

Globe Newswire SAN DIEGO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that company leadership will participate...\n more…